409 related articles for article (PubMed ID: 32837681)
1. A history of the roles of cytochrome P450 enzymes in the toxicity of drugs.
Guengerich FP
Toxicol Res; 2021 Jan; 37(1):1-23. PubMed ID: 32837681
[TBL] [Abstract][Full Text] [Related]
2. Roles of cytochrome P450 enzymes in pharmacology and toxicology: Past, present, and future.
Guengerich FP
Adv Pharmacol; 2022; 95():1-47. PubMed ID: 35953152
[TBL] [Abstract][Full Text] [Related]
3. A passion for P450s (rememberances of the early history of research on cytochrome P450).
Estabrook RW
Drug Metab Dispos; 2003 Dec; 31(12):1461-73. PubMed ID: 14625342
[TBL] [Abstract][Full Text] [Related]
4. Cytochrome P450s and other enzymes in drug metabolism and toxicity.
Guengerich FP
AAPS J; 2006 Mar; 8(1):E101-11. PubMed ID: 16584116
[TBL] [Abstract][Full Text] [Related]
5. Cytochrome p450 and chemical toxicology.
Guengerich FP
Chem Res Toxicol; 2008 Jan; 21(1):70-83. PubMed ID: 18052394
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Cytochrome P450 Enzymes by Drugs-Molecular Basis and Practical Applications.
Guengerich FP
Biomol Ther (Seoul); 2022 Jan; 30(1):1-18. PubMed ID: 34475272
[TBL] [Abstract][Full Text] [Related]
7. Role of cytochrome P450 enzymes in drug-drug interactions.
Guengerich FP
Adv Pharmacol; 1997; 43():7-35. PubMed ID: 9342171
[TBL] [Abstract][Full Text] [Related]
8. Mechanism-based inactivation of human cytochromes p450s: experimental characterization, reactive intermediates, and clinical implications.
Hollenberg PF; Kent UM; Bumpus NN
Chem Res Toxicol; 2008 Jan; 21(1):189-205. PubMed ID: 18052110
[TBL] [Abstract][Full Text] [Related]
9. Inhibition and induction of cytochrome P450 and the clinical implications.
Lin JH; Lu AY
Clin Pharmacokinet; 1998 Nov; 35(5):361-90. PubMed ID: 9839089
[TBL] [Abstract][Full Text] [Related]
10. The role of cytochrome P450 in cytotoxic bioactivation: future therapeutic directions.
Rooney PH; Telfer C; McFadyen MC; Melvin WT; Murray GI
Curr Cancer Drug Targets; 2004 May; 4(3):257-65. PubMed ID: 15134533
[TBL] [Abstract][Full Text] [Related]
11. Cytochrome P450: what have we learned and what are the future issues?
Guengerich FP
Drug Metab Rev; 2004 May; 36(2):159-97. PubMed ID: 15237850
[TBL] [Abstract][Full Text] [Related]
12. Cytochrome P450. Mechanisms of action and clinical implications.
Williams MT
J Fla Med Assoc; 1992 Jun; 79(6):405-8. PubMed ID: 1640215
[TBL] [Abstract][Full Text] [Related]
13. Drug Metabolism: A Half-Century Plus of Progress, Continued Needs, and New Opportunities.
Guengerich FP
Drug Metab Dispos; 2023 Jan; 51(1):99-104. PubMed ID: 35868640
[TBL] [Abstract][Full Text] [Related]
14. A novel cytochrome P450 mono-oxygenase from Streptomyces platensis resembles activities of human drug metabolizing P450s.
Worsch A; Eggimann FK; Girhard M; von Bühler CJ; Tieves F; Czaja R; Vogel A; Grumaz C; Sohn K; Lütz S; Kittelmann M; Urlacher VB
Biotechnol Bioeng; 2018 Sep; 115(9):2156-2166. PubMed ID: 29943426
[TBL] [Abstract][Full Text] [Related]
15. Reaction Phenotyping of Low-Turnover Compounds in Long-Term Hepatocyte Cultures Through Persistent Selective Inhibition of Cytochromes P450.
Smith S; Lyman M; Ma B; Tweedie D; Menzel K
Drug Metab Dispos; 2021 Nov; 49(11):995-1002. PubMed ID: 34407991
[TBL] [Abstract][Full Text] [Related]
16. Application of cytochrome P450 reactivity on the characterization of chemical compounds and its association with repeated-dose toxicity.
Watanabe M; Sasaki T; Takeshita JI; Kushida M; Shimizu Y; Oki H; Kitsunai Y; Nakayama H; Saruhashi H; Ogura R; Shizu R; Hosaka T; Yoshinari K
Toxicol Appl Pharmacol; 2020 Feb; 388():114854. PubMed ID: 31836524
[TBL] [Abstract][Full Text] [Related]
17. Designing better drugs: predicting cytochrome P450 metabolism.
de Groot MJ
Drug Discov Today; 2006 Jul; 11(13-14):601-6. PubMed ID: 16793528
[TBL] [Abstract][Full Text] [Related]
18. Mechanism-based inactivation of cytochrome P450 enzymes: chemical mechanisms, structure-activity relationships and relationship to clinical drug-drug interactions and idiosyncratic adverse drug reactions.
Kalgutkar AS; Obach RS; Maurer TS
Curr Drug Metab; 2007 Jun; 8(5):407-47. PubMed ID: 17584015
[TBL] [Abstract][Full Text] [Related]
19. In vitro inhibitory mechanisms and molecular docking of 1'-S-1'-acetoxychavicol acetate on human cytochrome P450 enzymes.
Haque AKMM; Leong KH; Lo YL; Awang K; Nagoor NH
Phytomedicine; 2017 Jul; 31():1-9. PubMed ID: 28606510
[TBL] [Abstract][Full Text] [Related]
20. Cytochrome P450 research and
Guengerich FP
J Biol Chem; 2019 Feb; 294(5):1671-1680. PubMed ID: 29871932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
